Product code QFA— Microbiology

WOUNDCHEK Bacterial Status

Classification name
Assay For Detection Of Proteases In Chronic Wounds
Device class
Class 2
Regulation
21 CFR 866.3231
Advisory panel
Microbiology
Total cleared
1
First cleared
Most recent

FDA classification definition

“A device to detect bacterial protease activity in chronic wound fluid is a lateral flow prescription device that may include a sterile swab. The device is intended for use in patients as an aid in assessing the risk for non-healing of chronic venous, diabetic foot, and pressure ulcers associated with wounds where there are no signs of wound infection and where patient are asymptomatic for clinical signs of infection.”

— U.S. Food and Drug Administration, device classification record for product code QFA under 21 CFR 866.3231, via openFDA

Market context for product code QFA

FDA has cleared 1 device under product code QFA, all in 2019, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code QFA

Recent clearances under product code QFA

Data sourced from openFDA. This site is unofficial and independent of the FDA.